Necker

Smart Immune Receives IRB Approval For Phase 1/2 Clinical Trial of Proprietary Allogeneic T-cell Product Smart-101 (ProTcell™) for AML and ALL

Retrieved on: 
Wednesday, October 13, 2021
Lymphatic system, Nominal interest rate, Genetic engineering, Technology, Program, Necker, Acute leukemia, Immune system, Publication, Mortality, IND, Institutional review board, AML, Leukemia, Immune reconstitution inflammatory syndrome, Doctor of Philosophy, Adult, Infection, Statistics, HSCT, MSK, Disease, Data management, FDA, CAR, Graft-versus-host disease, Clinical trial, Patient, ALL, GLOBE, Immunodeficiency, IRB, Memorial Sloan Kettering Cancer Center, Prognosis, SMART, Company, Investigational New Drug, MD, Safety, Hope, Culture, Pharmaceutical industry, Vaccine

In all cases, Smart-101 ProTcells will be cultured from the same donor from whom the patient has received the initial CD34+ HSCT.

Key Points: 
  • In all cases, Smart-101 ProTcells will be cultured from the same donor from whom the patient has received the initial CD34+ HSCT.
  • This trial will rely upon a prospectively generated control database of AML/ALL patients who undergo routine HSCTs at MSK.
  • Such proof can then pave the way for a more expedited clinical development of genetic engineered ProTcell in the future.
  • ProTcell is currently being studies in two clinical trials in Europe, with two in the U.S. expected to start in Q4 2021.

Sensorion Hosting Key Opinion Leader Call with Dr. John Greinwald on Genetic Hearing Loss in Children on December 2, 2020

Retrieved on: 
Friday, November 20, 2020
Science, Biotechnology, Research, Health, Children, Genetics, Consumer, Other Health, Hearing loss, Deafness, Medical specialties, Health sciences, Communication disorders, Occupational safety and health, Otorhinolaryngology, Sensorineural hearing loss, Necker, Causes of hearing loss, Pediatrics, Health

The call will feature a presentation by KOL John Greinwald Jr., MD, FAAP, Cincinnati Children's Hospital, who will discuss genetic forms of hearing loss in children.

Key Points: 
  • The call will feature a presentation by KOL John Greinwald Jr., MD, FAAP, Cincinnati Children's Hospital, who will discuss genetic forms of hearing loss in children.
  • Sensorion's management team will also discuss their strategy and approach to treating genetic forms of hearing loss and their key partnerships with Institut Pasteur and Necker-Enfants Malades Hospital in the field of genetic disorders of the inner ear.
  • Dr. John Greinwald is a tenured professor of Otolaryngology and Pediatrics with over 20 years of experience with a focus on the genetic causes and treatment of deafness.
  • He has pioneered the establishment of diagnostic evaluation algorithms for children with sensorineural hearing loss and developed a next generation sequencing platform to determine the genetic causes of hearing loss in children.

On Sir Branson's Necker Island, WIN announces Board of Advisors and new partnerships towards Global Citizen Forum

Retrieved on: 
Tuesday, April 9, 2019
Virgin Limited Edition, Knights Bachelor, Richard Branson, Necker, Aviation, British people, Economy of the United Kingdom

NECKER ISLAND, British Virgin Islands, April 9, 2019 /PRNewswire/ -- The World Identity Network (WIN) announces its Foundation's Board of Advisors and new partnerships towards convening the Global Citizen Forum in October this year.

Key Points: 
  • NECKER ISLAND, British Virgin Islands, April 9, 2019 /PRNewswire/ -- The World Identity Network (WIN) announces its Foundation's Board of Advisors and new partnerships towards convening the Global Citizen Forum in October this year.
  • Gathered on Sir Richard Branson's Necker Island, WIN's Board of Advisors includes leaders in the technology and humanitarian space, who're advancing human rights and advocate for a world of opportunity for all.
  • We're very proud to be partnering with Global Citizen Forum and ACTAI Global on this important endeavor."
  • ACTAI Global is a group of extraordinary athletes, conservationists, technologists and artists, whose collective passion brings them together to positively change the world.